Therapies directed towards blocking phospholipid synthesis activation by blocking c-Fos expression are promising moreover if it is considered that this protein is normally down regulated in healthy nervous tissue but becomes up-regulated during and is causally related to cancer progression. This evidence concerns the gene FOS and cancer.